Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelosuppression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00000691
What this trial is testing

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Testing effectiveness (Phase 2)WithdrawnNCT03692780
What this trial is testing

Careseng 1370 for Chemotherapy-Induced Myelosuppression

Who this might be right for
Chemotherapy-Induced Myelosuppression
Careseng Biotech Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT07671547
What this trial is testing

Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy

Who this might be right for
Breast CancerHematologic DisorderLeukopenia+1 more
MIPO Clinic 79
Testing effectiveness (Phase 2)Looking for participantsNCT06589089
What this trial is testing

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT05578326
What this trial is testing

Study of Trilaciclib and Lurbinectidin

Who this might be right for
Lung CancerSmall-cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center 30
Not applicableStudy completedNCT05912933
What this trial is testing

Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Who this might be right for
Breast Cancer
Pfizer 1,342
Not applicableEnded earlyNCT02375334
What this trial is testing

Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy

Who this might be right for
Malignant GliomaMyelosuppression
Wake Forest University Health Sciences 18
Not applicableUnknownNCT03846414
What this trial is testing

Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia

Who this might be right for
Chemotherapy-induced NeutropeniaMyelosuppression
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 1,500
Large-scale testing (Phase 3)Not Yet RecruitingNCT05780294
What this trial is testing

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Who this might be right for
Nasopharyngeal CarcinomaLeucogenChemotherapy+1 more
Sun Yat-sen University 132
Not applicableUnknownNCT00524797
What this trial is testing

Profonycia - Honey for Improving Quality of Patient's Life Receiving Chemotherapy

Who this might be right for
Myelosuppression
Ziv Hospital 50
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Large-scale testing (Phase 3)Ended earlyNCT00210730
What this trial is testing

The Duration Study

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2
Not applicableLooking for participantsNCT07819656
What this trial is testing

Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Myelosuppression
Nanfang Hospital, Southern Medical University 1,782
Testing effectiveness (Phase 2)Ended earlyNCT04887831
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab

Who this might be right for
Urothelial CarcinomaBladder CancerMyelosuppression Adult+2 more
G1 Therapeutics, Inc. 92
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06370416
What this trial is testing

The Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Who this might be right for
Non-small Cell Lung Cancer
Henan Cancer Hospital 41
Testing effectiveness (Phase 2)UnknownNCT00243165
What this trial is testing

Lifemel Honey to Reduce Leucopenia During Chemotherapy

Who this might be right for
Breast Cancer
Rambam Health Care Campus 60
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Testing effectiveness (Phase 2)Study completedNCT04477616
What this trial is testing

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 160
Not applicableStudy completedNCT03247010
What this trial is testing

Bone Marrow Suppression and Recovery During Radionuclide Treatment

Who this might be right for
Castration-resistant Prostate Cancer
Rigshospitalet, Denmark 68
Next Page